Stratos Wealth Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,163
Closed -$342K 634
2025
Q4
$342K Sell
4,163
-99
-2% -$7.71K 0.02% 505
2025
Q3
$320K Buy
4,262
+4
+0.1% +$298 0.02% 535
2025
Q2
$315K Buy
4,258
+405
+11% +$28.2K 0.02% 533
2025
Q1
$311K Buy
3,853
+89
+2% +$7.65K 0.02% 542
2024
Q4
$294K Sell
3,764
-202
-5% -$17.2K 0.01% 586
2024
Q3
$372K Buy
3,966
+15
+0.4% +$1.26K 0.02% 567
2024
Q2
$308K Buy
+3,951
New +$322K 0.02% 570
2023
Q4
Sell
-5,118
Closed -$348K 704
2023
Q3
$348K Buy
5,118
+499
+11% +$36.3K 0.02% 494
2023
Q2
$375K Sell
4,619
-1,449
-24% -$116K 0.03% 475
2023
Q1
$498K Buy
+6,068
New +$433K 0.04% 418

Other funds holding GEHC

Stratos Wealth Advisors's GEHC Position: Q1 2026 in Review

Stratos Wealth Advisors sold out of GE HealthCare (GEHC) in Q1 2026, closing a stake of 4,163 shares — an estimated $342K sold.

Stratos Wealth Advisors first reported a position in GEHC in Q1 2023 and held it in 10 quarters. The position peaked at $498K in Q1 2023. 1,265 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Stratos Wealth Advisors reported no remaining GE HealthCare position as of Q1 2026 after selling out during the quarter.
  • Stratos Wealth Advisors sold 4,163 GE HealthCare shares in Q1 2026, an estimated $342K.
  • Stratos Wealth Advisors first reported a position in GE HealthCare in Q1 2023 and held it in 10 quarters.
  • Stratos Wealth Advisors's GE HealthCare position peaked at $498K in Q1 2023.
  • 1,265 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Stratos Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.